Debra Senger to Join Heritage Board, Management

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Return to homepage

(TheNewswire)



  

Vancouver, B.C. / TheNewswire / September 5, 2018 – HERITAGE CANNABIS HOLDINGS CORPORATION (CSE: CANN) (“Heritage” or “Company”) announces the addition of Debra Senger, the CEO of PhyeinMed Inc. (“PhyeinMed”), to the board of Heritage. PhyeinMed is a subsidiary of Heritage, and an ACMPR Licensed Producer.

 

In addition to joining the board, Ms. Senger will also join the management team at Heritage, joining Clint Sharples as they build a team to lead the company into the future. Ms. Senger has led PhyeinMed for over four years and has been involved with public companies for over twenty years. She brings with her a deep knowledge of the Cannabis industry, and will play a key role in the strategic direction of Heritage.

 

“I would like to personally welcome Ms. Senger to the management team and the board of directors. I look forward to continuing our strong working relationship as we keep adding the pieces required to create a strong Cannabis company.” Says Clint Sharples, Chairman and interim CEO of Heritage.

 

About Heritage Cannabis Holdings Corporation

The Company is currently listed as a marijuana issuer having a 75% interest in PhyeinMed Inc, a Health Canada license holder under the ACMPR (Access to Cannabis for Medical Purposes Regulations). It is a Parent and Development Company with strategic plans to continue to acquire Cannabis related companies.

 

ON BEHALF OF THE BOARD OF DIRECTORS OF HERITAGE CANNABIS HOLDINGS CORPORATION

 

“Clint Sharples”

 

Clint Sharples

Chairman and Interim

President and CEO

 

For more information contact:

Clint Sharples

Tel:  416-705-8529

[email protected]


The Canadian Stock Exchange does not accept responsibility for the adequacy or accuracy of this release.

 

This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors - including the availability of funds, the results of financing efforts, the results of exploration activities -- that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

  

Copyright (c) 2018 TheNewswire - All rights reserved.